Stopping COPD inhalers can lead to higher risk of flare-ups for 3 months

Stopping long-acting inhalers for chronic obstructive pulmonary disease (COPD) can lead to a sharp rise in flare-ups for ...
Healio

Inhaler combination outperforms others in reducing COPD exacerbation, cardiovascular risks

Please provide your email address to receive an email when new articles are posted on . Outcomes may vary among different fixed-dose combination inhalers for COPD ...
Healio

Older age, more maintenance inhalers linked to high inhaled COPD medication adherence

Please provide your email address to receive an email when new articles are posted on . Less than 40% of the studied veteran cohort were adherent to their inhaled COPD medications. Adherence was found ...
MedPage Today

Environmentally Friendlier COPD Inhaler May Also Be More Effective

There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...
Healthline

Ask the Expert: What’s the Difference Between Short-Acting and Long-Acting Bronchodilators?

Short- and long-acting bronchodilators are inhaled medications that can be used separately or in combination to manage COPD.
The American Journal of Managed Care

Key Considerations in COPD When Utilizing Combination Therapy

The role of combination therapy is explored for the treatment of COPD. Jeffrey D. Dunn, PharmD, MBA: Let’s discuss guideline-based disease management. I’m going to address this first question to Rey.
Zacks Investment Research on MSN

GSK gets EU approval for expanded use of Nucala in COPD

GSK plc GSK announced that the European Commission has approved its blockbuster respiratory drug, Nucala (mepolizumab), for ...
Medscape

MHRA Approves First Low-Carbon COPD Inhaler for UK Patients

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the world’s first low-carbon version of a triple-combination inhaler for chronic obstructive pulmonary disease (COPD). The ...
MedPage Today

Switch to Dry-Powder Inhaler Worsened COPD, Asthma Patient Outcomes

Switching from a metered-dose to a dry-powder inhaler after a formulary change increased emergency department visits and hospitalizations in people with COPD or asthma. The absolute changes in risk ...
Morningstar

AeroRx Therapeutics Announces $21 Million Series A Financing to Advance Inhaled AERO-007, the First Nebulized LABA/LAMA for COPD, into Late-Stage Clinical Development

AeroRx Therapeutics, Inc., a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic respiratory diseases, today announced the closing of a $21 ...
The American Journal of Managed Care

Implementing Inhaled Corticosteroids (ICS) into COPD Patient Treatment Regimen

Inhaled corticosteroids (ICSs) are a key incorporation to COPD treatment strategies. Jeffrey D. Dunn, PharmD, MBA: ICSs [inhaled corticosteroids] haven’t shown much evidence in impacting the course of ...
Mena FN

Combination Inhalers Market To Grow At 6.3% CAGR Persistence Market Research

(MENAFN- EIN Presswire) EINPresswire/ -- The global Combination Inhalers Market is poised for steady expansion, driven by the rising burden of chronic respiratory diseases and continuous innovation in ...